OLEMA PHARMACEUTICALS INC (OLMA) Stock Balance Sheet
NASDAQ:OLMA - US68062P1066 - Common Stock
5.76 USD
+0.22 (+3.97%)
5.76 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 52.47M | 139.48M | 68.54M | 23.70M | 13.80M | |||
| Marketable Securities | 309.44M | 294.61M | 193.27M | 180.70M | 273.40M | |||
| Receivables | 1.83M | 2.12M | 673.00K | 300.00K | N/A | |||
| Other Current Assets | 3.98M | 2.27M | 4.03M | 4.20M | 3.40M | |||
| Total Current Assets | 367.73M | 438.47M | 266.51M | 208.90M | 290.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.25M | 2.06M | 3.26M | 4.00M | 4.70M | |||
| Other Non-Current Assets | 12.03M | 10.45M | 7.17M | 2.80M | 500.00K | |||
| Total Non-Current Assets | 14.28M | 12.51M | 10.43M | 6.70M | 5.20M | |||
| TOTAL ASSETS | 382.00M | 450.98M | 276.94M | 215.60M | 295.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 32.23M | 37.26M | 18.85M | 16.00M | 8.50M | |||
| Accounts Payable | 934.00K | 4.46M | 2.70M | 400.00K | 0.00 | |||
| Other Current Liabilities | 0.00 | 41.00K | 73.00K | 200.00K | 500.00K | |||
| Total Current Liabilities | 33.16M | 41.76M | 21.62M | 16.50M | 9.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.00M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 602.00K | 257.00K | 1.43M | 1.60M | 2.40M | |||
| Total Non-Current Liabilities | 3.60M | 257.00K | 1.43M | 1.60M | 2.40M | |||
| TOTAL LIABILITIES | 36.77M | 42.02M | 23.05M | 18.10M | 11.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -509.28M | -435.11M | -305.63M | -209.00M | -104.20M | |||
| Additional Paid In Capital | 854.19M | 843.92M | 559.18M | 408.30M | 388.90M | |||
| Common Shares | 7.00K | 6.00K | 4.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 314.00K | 143.00K | 347.00K | -1.80M | -100.00K | |||
| Shares Outstanding | 68.63M | 74.31M | 54.99M | 40.30M | 39.80M | |||
| Tangible Book Value per Share | 5.03 | 5.50 | 4.62 | 4.90 | 7.15 | |||
| Total Shareholders' Equity | 345.24M | 408.96M | 253.90M | 197.50M | 284.60M | |||
| TOTAL LIABILITIES AND EQUITY | 382.00M | 450.98M | 276.94M | 215.60M | 295.90M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 11.09 | 10.50 | 12.33 | 12.66 | 32.30 | |||
| Return On Assets (ROA) | -37.25% | -28.71% | -34.90% | -48.60% | -24.03% | |||
| Return On Equity (ROE) | -41.22% | -31.66% | -38.07% | -53.06% | -24.98% | |||
All data in USD , ROIC based on taxRate of 0.21